ON1231320 is primarily investigated for its potential applications in cancer therapy. It functions as a multi-kinase inhibitor, targeting specific enzymes involved in cell proliferation and survival. This makes it a promising candidate for treating various types of cancers, particularly those driven by abnormal kinase activity. Researchers are exploring its efficacy in preclinical studies, focusing on its ability to inhibit tumor growth and enhance the effectiveness of existing treatments. Additionally, its role in modulating signaling pathways associated with cancer progression is being studied to develop targeted therapies with fewer side effects compared to conventional chemotherapy.